| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0005 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |